QTc prolongation in COVID ‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta‐analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
QTc
prolongation in
COVID
‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta‐analysis
Authors
Keywords
-
Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume 30, Issue 6, Pages 694-706
Publisher
Wiley
Online
2021-03-27
DOI
10.1002/pds.5234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- COVID‐19 in solid organ transplant recipients: Initial report from the US epicenter
- (2020) Marcus R. Pereira et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
- (2020) John L. Sapp et al. CANADIAN JOURNAL OF CARDIOLOGY
- The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection
- (2020) Moussa Saleh et al. Circulation-Arrhythmia and Electrophysiology
- QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin
- (2020) Ehud Chorin et al. HEART RHYTHM
- Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association
- (2020) Dhanunjaya R. Lakkireddy et al. HEART RHYTHM
- QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
- (2020) Lior Jankelson et al. HEART RHYTHM
- ENHANCED ECG MONITORING OF COVID-19 PATIENTS
- (2020) Shashank Jain et al. HEART RHYTHM
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin
- (2020) Alberto Cipriani et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
- (2020) Eli S. Rosenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend
- (2020) Hor Chee Peng et al. JOURNAL OF INFECTION
- Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin
- (2020) David Chang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
- (2020) Ehud Chorin et al. NATURE MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chloroquine-induced QTc prolongation in COVID-19 patients
- (2020) M. P. H. van den Broek et al. Netherlands Heart Journal
- Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
- (2020) Matthieu Million et al. Travel Medicine and Infectious Disease
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
- (2020) Matthieu Mahévas et al. BMJ-British Medical Journal
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
- (2020) Francis Bessière et al. JAMA Cardiology
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- (2020) Caleb P. Skipper et al. ANNALS OF INTERNAL MEDICINE
- Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin
- (2020) Mary Kelly et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis
- (2020) Wei Liu et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Association of Hydroxychloroquine With QTc Interval in Patients With COVID-19
- (2020) Andrea Mazzanti et al. CIRCULATION
- Lopinavir-ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia
- (2020) Christophe Beyls et al. Circulation-Arrhythmia and Electrophysiology
- Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital
- (2020) Olivier Paccoud et al. CLINICAL INFECTIOUS DISEASES
- QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS‐CoV‐2 Lower Respiratory Tract Infection
- (2020) Sok‐Sithikun Bun et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Behavior of the PR interval with increasing heart rate in patients with COVID-19
- (2020) Behzad B. Pavri et al. HEART RHYTHM
- Incidence and determinants of QT interval prolongation in COVID‐19 patients treated with hydroxychloroquine and azithromycin
- (2020) Ilir Maraj et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients
- (2020) Nijad Bakhshaliyev et al. JOURNAL OF ELECTROCARDIOLOGY
- QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
- (2020) Brian C Hsia et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
- (2020) John R. Giudicessi et al. MAYO CLINIC PROCEEDINGS
- No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
- (2020) J.M. Molina et al. MEDECINE ET MALADIES INFECTIEUSES
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- (2020) Alexandre B. Cavalcanti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
- (2020) F. S. Sinkeler et al. Netherlands Heart Journal
- Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center
- (2020) Lucie Pothen et al. Travel Medicine and Infectious Disease
- Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
- (2020) Jean-Christophe Lagier et al. Travel Medicine and Infectious Disease
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation
- (2020) Anand Prakash Singh et al. Journal of Clinical Medicine
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Update Alert 2: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19
- (2020) Adrian V. Hernandez et al. ANNALS OF INTERNAL MEDICINE
- Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement
- (2020) Matteo Bertini et al. EUROPACE
- Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19
- (2020) Sergio Padilla et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
- (2020) Ehsan Sekhavati et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
- (2020) Andrea Bernardini et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
- (2020) Remo H M Furtado et al. LANCET
- Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection
- (2020) Philippe Giaime et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis
- (2020) Christopher W Jones et al. BMJ Open
- Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis
- (2020) Núria Farré et al. Journal of Clinical Medicine
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Acquired long QT syndrome in hospitalized patients
- (2017) Haixu Yu et al. HEART RHYTHM
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Prevention of Torsade de Pointes in Hospital Settings
- (2010) Barbara J. Drew et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation